249 related articles for article (PubMed ID: 33356836)
1. Pharmacological inactivation of CDK2 inhibits MYC/BCL-XL-driven leukemia in vivo through induction of cellular senescence.
Bazzar W; Bocci M; Hejll E; Högqvist Tabor V; Hydbring P; Grandien A; Alzrigat M; Larsson LG
Cell Cycle; 2021 Jan; 20(1):23-38. PubMed ID: 33356836
[TBL] [Abstract][Full Text] [Related]
2. Myc, Cdk2 and cellular senescence: Old players, new game.
Campaner S; Doni M; Verrecchia A; Fagà G; Bianchi L; Amati B
Cell Cycle; 2010 Sep; 9(18):3655-61. PubMed ID: 20818171
[TBL] [Abstract][Full Text] [Related]
3. Cdk2 suppresses cellular senescence induced by the c-myc oncogene.
Campaner S; Doni M; Hydbring P; Verrecchia A; Bianchi L; Sardella D; Schleker T; Perna D; Tronnersjö S; Murga M; Fernandez-Capetillo O; Barbacid M; Larsson LG; Amati B
Nat Cell Biol; 2010 Jan; 12(1):54-9; sup pp 1-14. PubMed ID: 20010815
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation.
Hydbring P; Bahram F; Su Y; Tronnersjö S; Högstrand K; von der Lehr N; Sharifi HR; Lilischkis R; Hein N; Wu S; Vervoorts J; Henriksson M; Grandien A; Lüscher B; Larsson LG
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):58-63. PubMed ID: 19966300
[TBL] [Abstract][Full Text] [Related]
5. MYC synergizes with activated BRAFV600E in mouse lung tumor development by suppressing senescence.
Tabor V; Bocci M; Alikhani N; Kuiper R; Larsson LG
Cancer Res; 2014 Aug; 74(16):4222-9. PubMed ID: 24934810
[TBL] [Abstract][Full Text] [Related]
6. Tipping the balance: Cdk2 enables Myc to suppress senescence.
Hydbring P; Larsson LG
Cancer Res; 2010 Sep; 70(17):6687-91. PubMed ID: 20713526
[TBL] [Abstract][Full Text] [Related]
7. p21 loss cooperates with INK4 inactivation facilitating immortalization and Bcl-2-mediated anchorage-independent growth of oncogene-transduced primary mouse fibroblasts.
Carbone CJ; Graña X; Reddy EP; Haines DS
Cancer Res; 2007 May; 67(9):4130-7. PubMed ID: 17483323
[TBL] [Abstract][Full Text] [Related]
8. Cdk2: a key regulator of the senescence control function of Myc.
Hydbring P; Larsson LG
Aging (Albany NY); 2010 Apr; 2(4):244-50. PubMed ID: 20445224
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the intrinsic but not the extrinsic apoptosis pathway accelerates and drives MYC-driven tumorigenesis towards acute myeloid leukemia.
Högstrand K; Hejll E; Sander B; Rozell B; Larsson LG; Grandien A
PLoS One; 2012; 7(2):e31366. PubMed ID: 22393362
[TBL] [Abstract][Full Text] [Related]
10. The BET Bromodomain Inhibitor JQ1 Suppresses Chondrosarcoma Cell Growth via Regulation of YAP/p21/c-Myc Signaling.
Zhang HT; Gui T; Sang Y; Yang J; Li YH; Liang GH; Li T; He QY; Zha ZG
J Cell Biochem; 2017 Aug; 118(8):2182-2192. PubMed ID: 28059436
[TBL] [Abstract][Full Text] [Related]
11. Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells.
Kang J; Sergio CM; Sutherland RL; Musgrove EA
BMC Cancer; 2014 Jan; 14():32. PubMed ID: 24444383
[TBL] [Abstract][Full Text] [Related]
12. Bcl-xL gain of function and p19 ARF loss of function cooperate oncogenically with Myc in vivo by distinct mechanisms.
Finch A; Prescott J; Shchors K; Hunt A; Soucek L; Dansen TB; Swigart LB; Evan GI
Cancer Cell; 2006 Aug; 10(2):113-20. PubMed ID: 16904610
[TBL] [Abstract][Full Text] [Related]
13. CDK2 is required by MYC to induce apoptosis.
Deb-Basu D; Aleem E; Kaldis P; Felsher DW
Cell Cycle; 2006 Jun; 5(12):1342-7. PubMed ID: 16760655
[TBL] [Abstract][Full Text] [Related]
14. Cdk2 deficiency decreases ras/CDK4-dependent malignant progression, but not myc-induced tumorigenesis.
Macias E; Kim Y; Miliani de Marval PL; Klein-Szanto A; Rodriguez-Puebla ML
Cancer Res; 2007 Oct; 67(20):9713-20. PubMed ID: 17942901
[TBL] [Abstract][Full Text] [Related]
15. c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations.
Luo H; Li Q; O'Neal J; Kreisel F; Le Beau MM; Tomasson MH
Blood; 2005 Oct; 106(7):2452-61. PubMed ID: 15972450
[TBL] [Abstract][Full Text] [Related]
16. MYC and RAS are unable to cooperate in overcoming cellular senescence and apoptosis in normal human fibroblasts.
Zhang F; Zakaria SM; Högqvist Tabor V; Singh M; Tronnersjö S; Goodwin J; Selivanova G; Bartek J; Castell A; Larsson LG
Cell Cycle; 2018; 17(24):2697-2715. PubMed ID: 30526305
[TBL] [Abstract][Full Text] [Related]
17. Escape from p21-mediated oncogene-induced senescence leads to cell dedifferentiation and dependence on anti-apoptotic Bcl-xL and MCL1 proteins.
de Carné Trécesson S; Guillemin Y; Bélanger A; Bernard AC; Preisser L; Ravon E; Gamelin E; Juin P; Barré B; Coqueret O
J Biol Chem; 2011 Apr; 286(15):12825-38. PubMed ID: 21292770
[TBL] [Abstract][Full Text] [Related]
18. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts.
Stein GH; Drullinger LF; Soulard A; Dulić V
Mol Cell Biol; 1999 Mar; 19(3):2109-17. PubMed ID: 10022898
[TBL] [Abstract][Full Text] [Related]
19. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
Shin J; Yang J; Lee JC; Baek KH
Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
[TBL] [Abstract][Full Text] [Related]
20. Endogenous Bcl-xL is essential for Myc-driven lymphomagenesis in mice.
Kelly PN; Grabow S; Delbridge AR; Strasser A; Adams JM
Blood; 2011 Dec; 118(24):6380-6. PubMed ID: 21998213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]